to achieve plasma concentrations of sitagliptin similar to those in patients with normal renal function, a dosage adjustment is recommended for patients with moderate renal insufficiency (50 mg ...

Sitagliptin (Januvia™) is a new oral agent ... and their interaction with DPP-4-related proteases. Potential side effects resulting from the alteration of action of these messengers include ...